Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2016 16:15 ET | Source: Stereotaxis, Inc.

Stereotaxis Common Stock to Begin Trading on OTCQX on August 4, 2016

ST. LOUIS, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that its shares...
August 02, 2016 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report Second Quarter 2016 Financial Results on August 9, 2016

ST. LOUIS, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will...
July 26, 2016 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Releases Second Generation V-CAS Deflect™ System in Europe

ST. LOUIS, July 26, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the market...
July 13, 2016 09:00 ET | Source: Stereotaxis, Inc.

University of Chicago Medicine Creating High-Tech Arrhythmia Technology Suite with Stereotaxis Niobe® ES System

ST. LOUIS, July 13, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the University...
July 08, 2016 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Niobe® ES System Installed at Texas Children’s Hospital

ST. LOUIS, July 08, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that Texas...
June 14, 2016 09:00 ET | Source: Stereotaxis, Inc.

Saint Alphonsus Physician Surpasses Procedure Milestone Using Stereotaxis Niobe® ES System

ST. LOUIS, June 14, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, and Saint Alphonsus Health System...
June 07, 2016 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Share its Latest Technology Advancements and Clinical Evidence at Cardiostim 2016 in Nice, France June 8-11

ST. LOUIS, June 07, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...
June 01, 2016 09:00 ET | Source: Stereotaxis, Inc.

Paracelsus Medical University Clinical Study on Stereotaxis Technology Benefits Recognized at European Cardiac Arrhythmia Society Congress

ST. LOUIS, June 01, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a...
May 09, 2016 16:05 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2016 First Quarter Financial Results

Ventricular tachycardia procedures increased 27% year over year, representing the third consecutive quarter of 20%+ volume growthFourth Niobe® system shipped to JapanPatient enrollment completed...
May 04, 2016 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis to Highlight New Clinical Results and Automation Enhancements at Heart Rhythm 2016 in San Francisco May 4-7

ST. LOUIS, May 04, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...